Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
Intervention1: Vecuronium with seodanalgesia with ketamine and or or midazolam: Children of age group between 1 month to 14 years presenting to Paediatric emergency planned for intubation will be enro
Intubation will be with induction agents as per standard guidelines with sedative and analgesics.
Control Intervention1: sedoanalgesia with ketamine and or or midazolam: Children of age group betwee
Intubation will be with induction agents as per standard guidelines with sedative and analgesics.
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children of age group between 1month to 14 years presenting to Paediatric emergency planned for intubation.
Exclusion criteria
Exclusion criteria: 1. Anticipated Difficult airway (anatomical) 2. Syndromic children 3. Children with neuromuscular disorders 4. Children with crush injuries 5. History of anaphylaxis to any NMBA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the Role of Neuromuscular Blocking Agent, Vecuronium in improving the first pass success of intubation in Pediatric emergencyTimepoint: Baseline during intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1To compare the ease of ventilation at intubation with without NMBA using a validated score Vibymogensen score 2 To compare the number of intubation attempts with & without NMBA including first pass success 3 To assess the time taken for intubation with & without NMBA 4 To assess the hemodynamic status & complications during intubation at intubation with & without NMBA Timepoint: Baseline during intubation | — |
Countries
India
Contacts
Public ContactAsha Jyothi Penugonda
AIIMS, Raipur
Outcome results
None listed